Arcus Biosciences GAAP EPS of -$0.89 beats by $0.14, revenue of $33M beats by $8.06M
Source: SeekingAlpha
2026-02-25 17:01:32 ET
More on Arcus Biosciences
- Arcus Biosciences, Inc. (RCUS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Arcus Biosciences, Inc. (RCUS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Arcus Biosciences: Casdatifan Takes Center Stage After STAR-221
- Arcus downgraded at Morgan Stanley on balanced risk-reward setup
- Gilead and Arcus halt late-stage study for anti-TIGIT cancer drug
Read the full article on Seeking Alpha
For further details see:
Arcus Biosciences GAAP EPS of -$0.89 beats by $0.14, revenue of $33M beats by $8.06M
Arcus Biosciences Inc.
NASDAQ: RCUS
RCUS Trading
1.53% G/L:
$21.86 Last:
324,898 Volume:
$21.79 Open:
RCUS Latest News
February 25, 2026 04:05:00 pm
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
RCUS Stock Data
$2,246,929,284
59,817,339
0.8%
67
N/A
Biotechnology & Life Sciences
Healthcare
US
Hayward
